“Immune Biomarkers of Percutaneous Coronary Intervention Adverse Outcomes in Myocardial Infarction and Stable Angina Patients”, AJP, vol. 12, no. 03, Nov. 2018, doi: 10.22377/ajp.v12i03.2653.